#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma non-metastatic Chronic graft versus host disease Ovarian cancer stage III Cystic fibrosis Red blood cell abnormality Multifocal motor neuropathy Henoch-Schonlein purpura nephritis B-cell small lymphocytic lymphoma recurrent Short stature Pseudomyxoma peritonei Desmoid tumour Fms-like tyrosine kinase 3 positive Haemolytic uraemic syndrome Immune-mediated myasthenia gravis Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Optic glioma Progressive multifocal leukoencephalopathy – Life with Disease Activated PI3 kinase delta syndrome – Life with Disease Von Willebrand’s disease – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Systemic sclerosis pulmonary – Basic Information Leiomyosarcoma metastatic – Treatment Behcet’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PICLIDENOSON Efmoroctocog Alfa Granisetron Erythromycin Lactobionate Betamethasone Ck-0045 Clonidine Hydrochloride Itacitinib Lanreotide Travoprost Ketotifen Hydrogen Fumarate Sabirnetug Acoramidis Hydrochloride Mb-Cart20.1 Deucravacitinib DCC-3084 Apl-101 Tulisokibart Doconexent Vixarelimab More therapies…

    Learn about Your Condition

    Cryoglobulinaemia Placenta praevia Brain neoplasm Tendon disorder Follicular thyroid cancer Small intestine adenocarcinoma Benign neoplasm of ureter Mucopolysaccharidosis II Papilloma viral infection Eye inflammation Acromegaly Systemic scleroderma Lymphangiosarcoma Kidney transplant rejection Mantle cell lymphoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    The Netherlands

  • Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Rilzabrutinib
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Safety and Effects of MK-3120 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • SKB410
    France The Netherlands Poland Spain

  • Study on Isoflurane, Propofol, and Dobutamine Hydrochloride for Sedation in Adults with Severe Cardiogenic Shock on ECMO

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Isoflurane
    • Propofol
    France

  • Study on Adding Darolutamide to First-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Darolutamide
    • Radium Ra 223 Dichloride
    Spain

  • Study on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17

    Recruiting

    3 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atogepant
    Denmark Hungary Italy The Netherlands Poland Portugal
Previous Page
1 … 209 210 211 212 213 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!